Drug Shortage Report for BUPIVACAINE INJECTION BP

Last updated on 2018-08-09 History
Report ID 51428
Drug Identification Number 02443686
Brand name BUPIVACAINE INJECTION BP
Common or Proper name BUPIVACAINE INJECTION BP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) BUPIVACAINE HYDROCHLORIDE
Strength(s) 2.5MG
Dosage form(s) SOLUTION
Route of administration BLOCK/INFILTRATION EPIDURAL
Packaging size 10 VIALS
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-06-01
Estimated end date 2018-06-22
Actual end date 2018-08-08
Shortage status Resolved
Updated date 2018-08-09
Company comments Product is on 100% allocation.
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-08-09 English Compare
v4 2018-08-08 French Compare
v3 2018-08-08 English Compare
v2 2018-06-05 French Compare
v1 2018-06-05 English Compare